![Guidance Gives Firms More Tools to Deal with Misinformation - Lachman Blog](https://www.lachmanconsultants.com/wp-content/uploads/2024/07/Guidance-Gives-Firms-More-Tools-to-Deal-with-Misinformation-Lachman-Blog.jpg)
Revised Q&A Guidance Gives Firms More Tools to Deal with Misinformation – Or Does It?
The FDA has just revised a guidance titled, “Addressing Misinformation About Medical Devices and Prescription Drugs: Questions and Answers” (here) which says: “This revised draft guidance, when finalized, will describe FDA’s current thinking on common questions firms may have when voluntarily addressing misinformation about or related to their approved/cleared medical products. This guidance revises and […]